RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

Investors riding a rare biotech recovery don’t need to jump off the train, but they should expect a bumpier ride. A mounting ...

PRESAGING PRASAD — The pharmaceutical industry is racing to understand top FDA vaccine regulator Vinay Prasad’s plan to ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

In the Large-Cap Pharmaceuticals industry, Lilly, J&J and Sanofi are worth retaining as the industry shows some recovery.

Fierce Biotech sat down with Pavel Raifeld, CEO of Innoviva, to explore the dynamic landscape of the biotech industry. Throughout the conversation, Raifeld offers a unique perspective on the most ...

F rom blockbuster drugs that garner media attention to smaller innovations that help millions maintain health, the biotech and pharmaceutical industries have an impact on everyone’s life. Meanwhile, ...

T he biotech and pharmaceutical sectors stand at the brink of innovation and strategic transformation. Market momentum continues to build, with the global biotechnology market valued at around $2 ...

Grogan served as assistant to President Trump and director of the Domestic Policy Council 2019-2020. On April 15, President Trump issued an awaited executive order on drug pricing, kicking off a new ...

Forecasters anticipate exponential growth throughout the biotech industry over the coming decade, paving the way for a series of stock market opportunities for investors throughout this period. The ...

The United States and Britain announced a deal on Monday to securezero tariffs on British pharmaceutical products and medical ...

From generics dominance to innovation leadership, India’s pharmaceutical sector is scaling rapidly through advanced ...